35 articles for thisTarget
The following articles (labelled with PubMed ID or TBD) are for your review
PMID
Cmpds
Data
Article Title
Organization
10
Acyclic tethers mimicking subunits of polysaccharide ligands: selectin antagonists.

Institut De Recherches Cliniques De Montr£Al (Ircm)
21
Optimization of highly selective 2,4-diaminopyrimidine-5-carboxamide inhibitors of Sky kinase.

Pfizer
4
A new approach to explore the binding space of polysaccharide-based ligands: selectin antagonists.

TBA
38
Rational design of novel, potent small molecule pan-selectin antagonists.

Revotar Biopharmaceuticals
9
Development of potent non-carbohydrate imidazole-based small molecule selectin inhibitors with antiinflammatory activity.

Ontogen
19
Novel synthetic inhibitors of selectin-mediated cell adhesion: synthesis of 1,6-bis[3-(3-carboxymethylphenyl)-4-(2-alpha-D- mannopyranosyloxy)phenyl]hexane (TBC1269).

Texas Biotechnology
13
Studies on selectin blockers. 7. Structure-activity relationships of sialyl Lewis X mimetics based on modified Ser-Glu dipeptides.

Kanebo
6
Studies on selection blockers. 5. Design, synthesis, and biological profile of sialyl Lewis x mimetics based on modified serine-glutamic acid dipeptides.

Kanebo
17
Sulfated galactocerebrosides as potential antiinflammatory agents.

Bristol Myers Squibb
8
Studies on selectin blocker. 1. Structure-activity relationships of sialyl Lewis X analogs.

Institute of Cancer Research
4
Studies on selectin blocker. 3. Investigation of the carbohydrate ligand sialyl Lewis X recognition site of P-selectin.

Kanebo
4
Studies on selectin blockers. 2. Novel selectin blocker as potential therapeutics for inflammatory disorders.

New Drug Research Laboratory
24
Rational design and synthesis of small molecule, non-oligosaccharide selectin inhibitors: (alpha-D-mannopyranosyloxy)biphenyl-substituted carboxylic acids.

Texas Biotechnology
1
Design and synthesis of a new sialyl Lewis X mimetic: how selective are the selectin receptors?

University of Montreal
3
A solid-phase synthesis for beta-turn mimetics of sialyl Lewis X.

Nippon Organon K.K.
16
Synthesis of sialyl Lewis X mimetics using the Ugi four-component reaction.

Scripps Research Institute
6
Discovery of 2-[1-(4-chlorophenyl)cyclopropyl]-3-hydroxy-8-(trifluoromethyl)quinoline-4-carboxylic acid (PSI-421), a P-selectin inhibitor with improved pharmacokinetic properties and oral efficacy in models of vascular injury.

Pfizer
8
Synthesis of fluorinated C-mannopeptides as sialyl Lewisx mimics for E- and P-selectin inhibition.

University of Rouen Normandy
2
Isolation and structure determination of sulfonoquinovosyl dipalmitoyl glyceride, a P-selectin receptor inhibitor from the alga Dictyochloris fragrans.

Bristol Myers Squibb
4
Chemical and enzymatic synthesis of high-affinity selectin ligands

TBA
1
Design and synthesis of an α-mannosyl terpenoid as selective inhibitor of P-selectin

TBA
7
Synthesis and biological activity of novel sialyl-lewis
X conjugates

TBA
6
Sialyl Lewisx Glycomimetics as E- and P-Selectin Antagonists Targeting Hyperinflammation.

University of Ottawa
4
Sialyl LewisX glycomimetics bearing an extended anionic chain targeting E- and P- selectin binding sites.

University of Montreal
50
2-(4-Chlorobenzyl)-3-hydroxy-7,8,9,10-tetrahydrobenzo[H]quinoline-4-carboxylic acid (PSI-697): identification of a clinical candidate from the quinoline salicylic acid series of P-selectin antagonists.

Wyeth Research
27
Recent advances in the discovery of heparanase inhibitors as anti-cancer agents.

Shandong University
35
Non-carbohydrate strategies to inhibit lectin proteins with special emphasis on galectins.

National Institute of Pharmaceutical Education and Research (NIPER)
1
Quinic acid derivatives as sialyl Lewis(x)-mimicking selectin inhibitors: design, synthesis, and crystal structure in complex with E-selectin.

Wyeth
8
Sialyl Lewis(x) analogs based on a quinic acid scaffold as the fucose mimic.

National Chemical Engineering Institute In Paris
83
Structural modification aimed for improving solubility of lead compounds in early phase drug discovery.

Indian Institute of Technology (B.H.U.)
1
Drug design, synthesis, and evaluation of a non-sugar-based selectin antagonist.

Organon K.K.
7
Aryl C-glycosides: physiologically stable glycomimetics of sialyl Lewis X.

Sankyo
11
Cinnamamide: An insight into the pharmacological advances and structure-activity relationships.

National Institute of Pharmaceutical Education and Research (NIPER)
3
Selectin-ligand interactions revealed by molecular dynamics simulation in solution.

Kanebo
2
Carbohydrates in an acidic multivalent assembly: nanomolar P-selectin inhibitors.

Lawrence Berkeley National Laboratories